Preferential methylation of Wnt inhibitory factor-1 in acute promyelocytic leukemia: an independent poor prognostic factor.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

14 citing papers in PubMed, 44 citations in OpenAlex.

1. Updated survivals and prognostic factor analysis in myeloma treated by a staged approach use of bortezomib/thalidomide/dexamethasone in transplant eligible patients.Journal of translational medicine · 2010
   Trial
2. Targeting β-catenin in acute myeloid leukaemia: past, present, and future perspectives.Bioscience reports · 2022
   Review
3. β-catenin induces expression of prohibitin gene in acute leukemic cells.Oncology reports · 2017
   Article
4. Wnt inhibitory factor 1 (WIF1) methylation and its association with clinical prognosis in patients with chondrosarcoma.Scientific reports · 2017
   Article
5. Arsenic trioxide increases expression of secreted frizzled-related protein 1 gene and inhibits the WNT/β-catenin signaling pathway in Jurkat cells.Experimental and therapeutic medicine · 2017
   Article
6. Significance of Inactivated Genes in Leukemia: Pathogenesis and Prognosis.Cell journal · 2017
   Review
7. Epigenetic alterations of the Wnt signaling pathway in cancer: a mini review.Bosnian journal of basic medical sciences · 2014
   Review
8. Deregulation of Wnt/β-catenin signaling through genetic or epigenetic alterations in human neuroendocrine tumors.Carcinogenesis · 2013
   Article
9. Distinct association between aberrant methylation of Wnt inhibitors and genetic alterations in acute myeloid leukaemia.British journal of cancer · 2011
   Article
10. Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms.Journal of translational medicine · 2011
    Article
11. Wnt signaling pathway is epigenetically regulated by methylation of Wnt antagonists in acute myeloid leukemia.Leukemia · 2009
    Article
12. WIF1, a Wnt pathway inhibitor, regulates SKP2 and c-myc expression leading to G1 arrest and growth inhibition of human invasive urinary bladder cancer cells.Molecular cancer therapeutics · 2009
    Article
13. Targeting the leukemic stem cell: the Holy Grail of leukemia therapy.Leukemia · 2009
    Review
14. The emerging role of Wnt signaling in the pathogenesis of acute myeloid leukemia.Leukemia · 2007
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

4 authors at 1 institution in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as